<DOC>
	<DOCNO>NCT00884234</DOCNO>
	<brief_summary>The purpose study determine safety efficacy 2 sequential dos RT001 compare vehicle control follow application Baseline ( Day 0 ) Week 2 .</brief_summary>
	<brief_title>Safety Efficacy Study RT001 Treat Moderate Severe Lateral Canthal Lines</brief_title>
	<detailed_description>This double-blind , randomize , parallel-group , control , repeat dose , single center study evaluate safety efficacy repeat application RT001 least 30 subject moderate severe lateral canthal line . Subjects randomize 1 2 treatment group 1:1 ratio ( RT001 Dose A vehicle control ) .</detailed_description>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Female/male age 30 55 2 . Bilateral lateral canthal line rat moderate advance . 3 . Willing refrain product affect skin remodel product may cause active dermal response treatment area begin screen Week 6 . 4 . Women child bar potential must practice willing continue use effective method birth control . 1 . Muscle weakness paralysis area receive treatment . 2 . Active skin disease irritation treatment area . 3 . Undergone procedure may affect lateral canthal region past 12 month prior screen . 4 . Previous treatment botulinum toxin ( serotype ) head neck area within 9 month prior Baseline ( Day 0 ) . 5 . Use topical steroid either treatment area use medication suppress immune system 30 day prior screen continue End Study ( Week 6 ) . 6 . Any abnormality electrocardiogram ( ECG ) screen history clinically significant arrhythmia , unstable angina , myocardial infarction congestive hear failure .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Lateral Canthal Lines</keyword>
	<keyword>Crow 's Feet</keyword>
	<keyword>Facial Wrinkles</keyword>
	<keyword>Lateral Canthal Area</keyword>
</DOC>